TIL - Instil Bio

-

$undefined

N/A

(N/A)

Instil Bio NASDAQ:TIL Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing an innovative cell therapy pipeline of autologous TIL therapies for the treatment of patients with cancer.

Location: | Website: instilbio.com | Industry: Research and Development in Biotechnology | Sector: Professional, Scientific, and Technical Services


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

56.97M

Cash

113.3M

Avg Qtr Burn

-13.92M

Short % of Float

24.12%

Insider Ownership

12.76%

Institutional Own.

79.94%

Qtr Updated

12/31/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.